Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel
Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an in...
Gespeichert in:
Veröffentlicht in: | The Israel Medical Association journal 2004-04, Vol.6 (4), p.201-204 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 204 |
---|---|
container_issue | 4 |
container_start_page | 201 |
container_title | The Israel Medical Association journal |
container_volume | 6 |
creator | Moshkowitz, Menachem Baruch, Efrat Ben Kline, Zeev Gelber, Moshe Shimoni, Zvi Konikoff, Fred |
description | Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes.
To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population.
We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease.
Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, > 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC.
The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates. |
format | Article |
fullrecord | <record><control><sourceid>pubmed_igdc_</sourceid><recordid>TN_cdi_pubmed_primary_15115256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15115256</sourcerecordid><originalsourceid>FETCH-LOGICAL-i229t-5ae13d5a6ad3c9981d38a05d2f7ac5fb2850c0165925f1de41439136223659063</originalsourceid><addsrcrecordid>eNo1j8tOwzAURL0A0VL4BJB_IJIfvSZZoopHpUpsYB3d-FEucuwoThb9ewKF1YxmjkaaC7aWYKCSoq5X7LqULyEUgGiu2EqClKDArFm3i5TIYuQ9Jgq-TDhRToVjcjzPk8295znwofjZLb7vRkx5LtzmSBMVTmlBuY_Oj_HEhzzM8Xfhp9iXEX28YZcBY_G3f7phH89P77vX6vD2st89HipSqpkqQC-1AzTotG2aWjpdowCnwgNaCJ2qQVghDTQKgnR-K7e6kdoopZdMGL1h9-fdYe5679phpB7HU_t_dgHuzgAdnW076iLl44jDJ9lWQa2_AVBOWtg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Moshkowitz, Menachem ; Baruch, Efrat Ben ; Kline, Zeev ; Gelber, Moshe ; Shimoni, Zvi ; Konikoff, Fred</creator><creatorcontrib>Moshkowitz, Menachem ; Baruch, Efrat Ben ; Kline, Zeev ; Gelber, Moshe ; Shimoni, Zvi ; Konikoff, Fred</creatorcontrib><description>Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes.
To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population.
We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease.
Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, > 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC.
The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates.</description><identifier>ISSN: 1565-1088</identifier><identifier>PMID: 15115256</identifier><language>eng</language><publisher>Israel</publisher><subject>Adult ; Aged ; Anti-Bacterial Agents - adverse effects ; Enterocolitis, Pseudomembranous - chemically induced ; Enterocolitis, Pseudomembranous - diagnosis ; Enterocolitis, Pseudomembranous - drug therapy ; Female ; Humans ; Male ; Metronidazole - therapeutic use ; Middle Aged ; Retrospective Studies</subject><ispartof>The Israel Medical Association journal, 2004-04, Vol.6 (4), p.201-204</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786</link.rule.ids><backlink>$$Uhttp://igdc.huji.ac.il/home/Maagar/Details.aspx?AN=258$$D View record in IGDC$$Hfree_for_read</backlink><backlink>$$Uhttp://www.ima.org.il/FilesUpload/IMAJ/0/51/25995.pdf$$D View full text (Access may be restricted)$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15115256$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moshkowitz, Menachem</creatorcontrib><creatorcontrib>Baruch, Efrat Ben</creatorcontrib><creatorcontrib>Kline, Zeev</creatorcontrib><creatorcontrib>Gelber, Moshe</creatorcontrib><creatorcontrib>Shimoni, Zvi</creatorcontrib><creatorcontrib>Konikoff, Fred</creatorcontrib><title>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</title><title>The Israel Medical Association journal</title><addtitle>Isr Med Assoc J</addtitle><description>Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes.
To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population.
We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease.
Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, > 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC.
The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates.</description><subject>Adult</subject><subject>Aged</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Enterocolitis, Pseudomembranous - chemically induced</subject><subject>Enterocolitis, Pseudomembranous - diagnosis</subject><subject>Enterocolitis, Pseudomembranous - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Metronidazole - therapeutic use</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><issn>1565-1088</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tOwzAURL0A0VL4BJB_IJIfvSZZoopHpUpsYB3d-FEucuwoThb9ewKF1YxmjkaaC7aWYKCSoq5X7LqULyEUgGiu2EqClKDArFm3i5TIYuQ9Jgq-TDhRToVjcjzPk8295znwofjZLb7vRkx5LtzmSBMVTmlBuY_Oj_HEhzzM8Xfhp9iXEX28YZcBY_G3f7phH89P77vX6vD2st89HipSqpkqQC-1AzTotG2aWjpdowCnwgNaCJ2qQVghDTQKgnR-K7e6kdoopZdMGL1h9-fdYe5679phpB7HU_t_dgHuzgAdnW076iLl44jDJ9lWQa2_AVBOWtg</recordid><startdate>20040401</startdate><enddate>20040401</enddate><creator>Moshkowitz, Menachem</creator><creator>Baruch, Efrat Ben</creator><creator>Kline, Zeev</creator><creator>Gelber, Moshe</creator><creator>Shimoni, Zvi</creator><creator>Konikoff, Fred</creator><scope>AGDVQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20040401</creationdate><title>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</title><author>Moshkowitz, Menachem ; Baruch, Efrat Ben ; Kline, Zeev ; Gelber, Moshe ; Shimoni, Zvi ; Konikoff, Fred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i229t-5ae13d5a6ad3c9981d38a05d2f7ac5fb2850c0165925f1de41439136223659063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Enterocolitis, Pseudomembranous - chemically induced</topic><topic>Enterocolitis, Pseudomembranous - diagnosis</topic><topic>Enterocolitis, Pseudomembranous - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Metronidazole - therapeutic use</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moshkowitz, Menachem</creatorcontrib><creatorcontrib>Baruch, Efrat Ben</creatorcontrib><creatorcontrib>Kline, Zeev</creatorcontrib><creatorcontrib>Gelber, Moshe</creatorcontrib><creatorcontrib>Shimoni, Zvi</creatorcontrib><creatorcontrib>Konikoff, Fred</creatorcontrib><collection>IGDC Bibliographic Database - מאגר לחקר ההזדקנות</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Israel Medical Association journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moshkowitz, Menachem</au><au>Baruch, Efrat Ben</au><au>Kline, Zeev</au><au>Gelber, Moshe</au><au>Shimoni, Zvi</au><au>Konikoff, Fred</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel</atitle><jtitle>The Israel Medical Association journal</jtitle><addtitle>Isr Med Assoc J</addtitle><date>2004-04-01</date><risdate>2004</risdate><volume>6</volume><issue>4</issue><spage>201</spage><epage>204</epage><pages>201-204</pages><issn>1565-1088</issn><abstract>Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity, mortality and cost. Clostridium difficile infection is the single most important infectious cause of PMC. PMC is frequently nosocomial, with an increased risk of spread among institutionalized patients, both in hospitals and nursing homes.
To investigate the demographic, clinical and laboratory characteristics of PMC patients in an Israeli elderly population.
We studied 72 hospitalized patients with endoscopically proven PMC. The medical records of all patients including clinical history and laboratory data were reviewed, such as: age, pre-hospitalization status (dependency or not, in the community as compared to the nursing home), background medical history, presenting symptoms, antibiotic history, physical examination on admission, hematologic and biochemical parameters, treatment, duration of hospitalization, complications, mortality, and recurrence of disease.
Of the 72 patients (34 males and 38 females, mean age 77 years) 47% were nursing home residents. Pre-hospitalization antibiotic treatment was given to 91.4% for infections of the upper respiratory tract (45%) and urinary tract (45%). The most common antibiotics were cephalosporin (64%), penicillins (42%) and quinolones (28%). Sixty-four percent of the patients were treated with more than one antibiotic, 26% of patients received anti-acid therapy and 36% had been fed with a nasogastric tube. On admission, leukocytosis was found in 79% of patients, > 20,000/mm3 in half of them; 60% were anemic, 60% had elevated erythrocyte sedimentation rate, and 78% had hypoalbuminemia. Treatment consisted of metronidazole (41%) or a combination of metronidazole and vancomycin (56%). Overall, 31% of patients recovered without complications, 29% died within 30 days of hospitalization, and 24% were re-hospitalized due to recurrence of PMC.
The most common antibiotics implicated in PMC are cephalosporin, penicillins and quinolones. The disease is associated with high mortality and recurrence rates.</abstract><cop>Israel</cop><pmid>15115256</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1565-1088 |
ispartof | The Israel Medical Association journal, 2004-04, Vol.6 (4), p.201-204 |
issn | 1565-1088 |
language | eng |
recordid | cdi_pubmed_primary_15115256 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adult Aged Anti-Bacterial Agents - adverse effects Enterocolitis, Pseudomembranous - chemically induced Enterocolitis, Pseudomembranous - diagnosis Enterocolitis, Pseudomembranous - drug therapy Female Humans Male Metronidazole - therapeutic use Middle Aged Retrospective Studies |
title | Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T09%3A53%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_igdc_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20manifestations%20and%20outcome%20of%20pseudomembranous%20colitis%20in%20an%20elderly%20population%20in%20Israel&rft.jtitle=The%20Israel%20Medical%20Association%20journal&rft.au=Moshkowitz,%20Menachem&rft.date=2004-04-01&rft.volume=6&rft.issue=4&rft.spage=201&rft.epage=204&rft.pages=201-204&rft.issn=1565-1088&rft_id=info:doi/&rft_dat=%3Cpubmed_igdc_%3E15115256%3C/pubmed_igdc_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/15115256&rfr_iscdi=true |